Covered recipient · General Payments record
CYNTHIA R SOULERET
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$886.17
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $520.78 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $250.89 | 7 |
| Janssen Pharmaceuticals, Inc | $104.46 | 1 |
| ABBVIE INC. | $45.48 | 2 |
| Braeburn Inc. | $33.78 | 2 |
| ITI, Inc. | $23.58 | 1 |
| Otsuka America Pharmaceutical, Inc. | $22.50 | 1 |
| Noven Therapeutics, LLC | $20.72 | 1 |
| Indivior Inc. | $19.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.11 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108233752 | CMS |
| ABBVIE INC. | $13.37 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108233754 | CMS |
| Alkermes, Inc. | $22.07 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120601390 | CMS |
| Alkermes, Inc. | $23.20 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120601392 | CMS |
| Alkermes, Inc. | $20.66 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120601394 | CMS |
| Alkermes, Inc. | $14.71 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120601396 | CMS |
| Alkermes, Inc. | $31.99 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120601398 | CMS |
| Alkermes, Inc. | $109.48 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120601400 | CMS |
| Alkermes, Inc. | $28.78 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120601402 | CMS |
| Braeburn Inc. | $17.88 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125612189 | CMS |
| Braeburn Inc. | $15.90 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125612191 | CMS |
| Indivior Inc. | $19.37 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144571867 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.58 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143607852 | CMS |
| Janssen Pharmaceuticals, Inc | $104.46 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077948056 | CMS |
| Noven Therapeutics, LLC | $20.72 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084829828 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.50 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119190334 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.